Features of Early Diagnosis, Causal Treatment and Chemoprophylaxis of Influenza
DOI:
https://doi.org/10.22141/2312-413x.1.01.2013.82616Keywords:
influenza, treatment, chemoprophylaxis, zanamivir, oseltamivir, rimantadineAbstract
The article describes the main methods of diagnosis of influenza in different periods of the disease. Also presents current approaches to the causal treatment of influenza with adduction of main medicationds, which can be used for treatment. Modern features of influenza chemoprophylaxis are given.
References
Бенца Т.М. Гострі респіраторні вірусні захворювання: сучасні підходи до лікування та профілактики (лекція) // Сімейна медицина. — 2011. — № 1. — С. 25-29.
Лещенко И.В., Кривоногов А.В. Особенности течения пневмонии при пандемическом гриппе А/H1N1/09 // Пульмонология. — 2011. — № 6. — С. 62-68.
Малий В.П., Гололобова О.В. Противірусна терапія хворих на грип // Клінічна імунологія. Алергологія. Інфектологія. — 2011. — № 4 (43). — С. 53-56.
Фартушок Т.В. Вірус грипу та вагітність // Актуальні питання педіатрії, акушерства та гінекології. — 2011. — № 1. — С. 180-182.
Наказ від 20.05.2009 № 189-Адм «Про затвердження "Протоколу діагностики та лікування нового грипу A (H1/N1) — Каліфорнія у дорослих"» МОЗ України. http://mozdocs.kiev.ua/view.php?id=10568
Киселев О.И., Малый В.П., Зарубабаев В.В. и др. Грипп А H1N1 как типичная эмерджентная инфекция (вирусологические, клинико-эпидемиологические особенности, вопросы терапии и профилактики. — СПб.; Харьков; Ужгород, 2009. — 43 с.
Львов Д.К., Забережный А.Д., Алипер Т.И. Вирусы гриппа: события и прогнозы // Природа. — 2006. — № 6.
Webster R.G., Bean W.J., German O.T. et al. // Microbiol. Rev. — 1992. — V. 56. — P. 152-179.
James C. Paulson, Gary N. Rogers, Susan N. Carroll, Herman H. Higa and other, Selection of influenza virus variants based on sialyloligosaccharide receptor specificity // Pure & Appi. — 1984. — Vol. 56, № 7. — Р. 797-805.
Канивец Е. Эпидемиологические особенности гриппа, методы лечения и профилактики // Клінічна імунологія. Алергологія. Інфектологія. — 2012. — № 9 (58). — С. 13-16.
Екимов А.Н., Шипулин Г.А., Бочкарев Е.Г. и др. Новейшие технологии в генодиагностике: полимеразная цепная реакция в реальном времени (Real-Time PCR) // Вестник последипломного медицинского образования. — 2001. — № 3. — С. 4-8.
Harper S.A., Bradley J.S., Englund J.A. et al. Expert Panel of the Infectious Diseases Society of America. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America // Clin. Infect. Dis. — 2009 Apr 15. — 48(8). — 1003-32.
Крамарєв С.О. Особенности диагностики и лечения гриппа у детей / Крамарєв С.О. // Мат-ли науково-практичної конференції з міжнародною участю «Актуальные инфекционные заболевания: клиника, диагностика, лечение и профилактика». — К., 2010.
Hsu J., Santesso N., Mustafa R. et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies // Ann. Intern. Med. — 2012. — 156 (7). — 512-524.
Health Protection Agency guidance on use of antiviral agents for the treatment and prophylaxis of influenza, 12 December 2011. http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/1191942171479
Nicholson K.G. Use of antivirals in influenza in the elderly: prophylaxis and therapy // Gerontology. — 1996. — 42. — 280-289.
Зайцев А.А., Синопальников А.И. Грипп: диагностика, лечение // РМЖ. — 2008. — № 16 (22). — С. 1494-1502.
Centers for Disease Control and Prevention. http://www.cdc.gov/flu
Бурцева Е.И., Шевченко Е.С., Ленева И.А. и др. Чувствительность к римантадину и арбидолу вирусов гриппа, вызвавших эпидемические подъемы заболеваемости в России в сезоне 2004–2005 гг. // Вопросы вирусологии. — 2007. — № 2. — С. 24-29.
Міроненко А.П., Голубка О.С., Онищенко О.В. та ін. Результати моніторингу вірусів грипу, що циркулюють в Україні, до противірусних препаратів // Український медичний часопис. — 2013. — № 1 (93). — С. 85-86.
Govorkova E.A., Baranovich T., Seiler P. et al. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002–2012 shows need for continued monitoring // Antiviral. Res. — 2013 May. — 98(2). — 297-304.
Hall C.B., Dolin R., Gala C.L. et al. Children with influenza A infection: treatment with rimantadine // Pediatrics. — 1987. — 80. — 275-82.
Наказ Міністерства охорони здоров’я України від 11.05.2011 № 267 «Про затвердження «Інструкції для медичного застосування медичного препарату ремавір 20 мг». http://olfa.ua/preparations/iRemavir_P-20.pdf
Nichol K.L., Treanor J.J. Vaccines for seasonal and pandemic influenza // J. Infect. Dis. — 2006. — 194 (Suppl. 2). — S111-8.
Besselaar T.G., Dhamari N., Buys A. et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa // Emerg. Infect. Dis. — 2008. — 14. — 1809-10.
Ciancio B., Fernandez de la Hoz K., Kreidl P. et al. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update // Euro Surveill. — 2008. — 13. — 8032.
Lackenby A., Hungnes O., Dudman S.G. et al. Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe // Euro Surveill. — 2008. — 13. — 8026.
CDC issues interim recommendations for the use of influenza antiviral medications in the settingof oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008–09 influenza season. 2008. — Centers for Disease Control and Prevention. http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNump00279
WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza VirusesRevised February 2010. — World Health Organization, Global Alert and Response (GAR). http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf
Kaiser L., Wat C., Mills T., Mahoney P., Ward P., Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations // Arch. Intern. Med. — 2003. — 163. — 1667-72.
Hayden F.G., Belshe R., Villanueva C. et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis // J. Infect. Dis. — 2004. — 189. — 440-9.
Monto A.S., Pichichero M.E., Blanckenberg S.J. et al. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households // J. Infect. Dis. — 2002. — 186. — 1582-8.
Highlights of prescribing information Roche. Oseltamivir. Nutley, NJ: Roche, 2008. http://www.rocheusa.com/products/tamiflu/pi.pdf
Centers for Disease Control and Prevention. СDC: Who Should not Get Vaccinated with these Vaccines? http://www.cdc.gov/vaccines/vpd-vac/should-not-vacc.htm#flu
Welliver R., Monto A.S., Carewicz O. et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial // JAMA. — 2001. — 285. — 748-54.
Rubin M.S., Nivin B., Ackelsberg J. Effect of timing of amantadine chemoprophylaxis on severity of outbreaks of influenza A in adult long-term care facilities // Clin. Infect. Dis. — 2008. — 47. — 47-52.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 ACTUAL INFECTOLOGY
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
